Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
06:45pm, Friday, 01'st May 2026
Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Friday, 01'st May 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:01am, Thursday, 30'th Apr 2026
Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
04:00pm, Wednesday, 29'th Apr 2026
GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 27'th Apr 2026
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Outperforms Broader Market: What You Need to Know
06:46pm, Friday, 17'th Apr 2026
Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 15'th Apr 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 13'th Apr 2026
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of “Hold” from Analysts
02:18am, Monday, 13'th Apr 2026
Shares of Novavax, Inc. (NASDAQ: NVAX - Get Free Report) have received an average rating of "Hold" from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts hav
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
06:46pm, Thursday, 09'th Apr 2026
In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day.
Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy
10:54am, Wednesday, 08'th Apr 2026
The investor, which holds roughly 9% of the company, argued that leadership has failed to translate Novavax's vaccine platform into meaningful commercial success.
Shah Capital intends to vote against Novavax's board nominees, executive compensation
06:08am, Wednesday, 08'th Apr 2026
Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's upcoming annual meeting, renewing pressure for changes
Traders Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX)
01:25am, Tuesday, 07'th Apr 2026
Novavax, Inc. (NASDAQ: NVAX - Get Free Report) saw some unusual options trading on Monday. Stock investors purchased 21,020 call options on the stock. This is an increase of approximately 71% compared
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
06:45pm, Wednesday, 01'st Apr 2026
In the closing of the recent trading day, Novavax (NVAX) stood at $8.02, denoting a -1.47% move from the preceding trading day.
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average – Here’s Why
02:11am, Tuesday, 31'st Mar 2026
Novavax, Inc. (NASDAQ: NVAX - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $8.28 and traded as high as
